Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood-Reference-Cited by-同舟云学术

Inhibition of antithrombin by protein SV-IV normalizes the coagulation of hemophilic blood

Published:2000-03 Issue:1-2 Volume:391 Page:1-9
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Di Micco Biagio,Caen Jacques,Colonna Giovanni,Macalello Maria A,Marchese Magda,Stiuso Paola,Di Micco Pierpaolo,Morelli Francesco,Metafora Salvatore

Publisher

Elsevier BV

Subject

Pharmacology

Reference53 articles.

1. Maturation in different translational systems of the protein RSV-IV secreted from the rat seminal vesicle epithelium;Abrescia;Bull. Mol. Biol. Med.,1986

2. Molecular etiology of factor VIII deficiency in hemophilia A;Antonarakis;Hum. Mutat.,1995

3. Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor;Bajzar;J. Biol. Chem.,1998

4. Thrombin-dependent inhibition of fibrinolysis;Broze;Curr. Top. Hematol.,1996

5. Coagulation-dependent inhibition of fibrinolysis: role of carboxypeptidase-U and the premature lysis of clots from hemophilic plasma;Broze;Blood,1996

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging Therapeutic Strategies in the Treatment of Hemophilia A;Seminars in Thrombosis and Hemostasis;2017-07-27

2. An RNAi therapeutic targeting antithrombin to rebalance the coagulation system and promote hemostasis in hemophilia;Nature Medicine;2015-04-13

3. The N-terminal 1-16 peptide derived in vivo from protein seminal vesicle protein IV modulates α-thrombin activity: potential clinical implications;Experimental and Molecular Medicine;2008

4. SV-IV Peptide1–16 reduces coagulant power in normal Factor V and Factor V Leiden;Journal of Translational Medicine;2007-12

5. Seminal Vesicle Protein IV and Its Derived Active Peptides: A Possible Physiological Role in Seminal Clotting;Seminars in Thrombosis and Hemostasis;2007-02